Login / Signup

Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model.

Hyejeong KimMinyoung NohHaiying ZhangYeomyeong KimSongyi ParkJeongeun ParkYoung-Guen Kwon
Published in: Fluids and barriers of the CNS (2023)
These findings suggest that CU06-1004 may represent a promising therapeutic approach for delaying age-related cerebrovascular impairment and improving cognitive function in old age.
Keyphrases
  • mouse model
  • blood brain barrier
  • aqueous solution